SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Teva Pharmaceuticals
TEVA 31.22-0.4%Dec 31 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLLefty who wrote (225)7/9/1998 2:55:00 PM
From: Harold Engstrom  Read Replies (1) of 340
 
I also think Teva now represents a good opportunity. Management should still be viewed with suspicion, but the company makes money and its products are selling well. COP-1, although not a very effective MS treatment, is the only real alternative to interferon treatments and is pulling many betaseron takers away from Schering. It's trading at 15X the past 4 quarters' earnings: pretty attractive relative to the rest of the market. If the company can stop talking and just quietly put up good numbers, Teva stock should appreciate nicely.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News